Lund University:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Lund University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C5164
◆発行会社(調査会社):GlobalData
◆発行日:2018年9月
◆ページ数:53
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:スウェーデン
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Lund University (LNU) is an educational service provider that offers master and bachelor programmes. It offers education and research in the areas of engineering, economics and management, science, law, social sciences, medicine, humanities, theology, fine art, music and others. The university spans its expertise in cancer research, neuroscience and neurodegenerative diseases, diabetes, stem cell therapy, epidemiology, Middle Eastern studies, materials science, and nanotechnology among others. It works in collaboration with other universities through international networks, cooperation platforms for research and education. LNU is headquartered in Lund, Sweden.

Lund University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 5
List of Figures 5
Lund University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Lund University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Lund University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Lund University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Lund University, Medical Devices Deals, 2012 to YTD 2018 10
Lund University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
Lund University, Pharmaceuticals & Healthcare, Deal Details 12
Partnerships 12
RhoVac Enters into Research Agreement with Lund University 12
Rocket Pharma Entered into Research and Development Agreement with Lund University 13
Licensing Agreements 14
Novo Nordisk Enters into Research and Licensing Agreement with Lund University 14
Avrobio Enters into Licensing Agreement with Lund University 15
Equity Offering 16
Akuru Pharma Spin Out from Lund University 16
Lund University – Key Competitors 17
Lund University – Key Employees 18
Lund University – Locations And Subsidiaries 19
Head Office 19
Other Locations & Subsidiaries 19
Joint Venture 20
Recent Developments 21
Government and Public Interest 21
Aug 29, 2018: Lund University research group receives follow-on DKK 1 million grant from Novo Nordisk Foundation for diabetes-related studies with Follicum peptides 21
Aug 22, 2018: New method grows brain cells from stem cells quickly and efficiently 22
Aug 21, 2018: Powerful molecules provide new findings about Huntington’s disease 24
Apr 18, 2018: Similarity between high-risk atherosclerotic plaque and cancer cells discovered 26
Apr 16, 2018: Hope for new treatment of severe epilepsy 27
Apr 09, 2018: Jan Sundquist at Lund University awarded an ERC Advanced Grant 28
Apr 06, 2018: Mechanism vital to keeping blood stem cells functional uncovered 29
Apr 03, 2018: Breakthrough for dangerous blood transfusion-related disease 30
Mar 02, 2018: Paradigm shift in the diagnosis of diabetes 31
Nov 30, 2017: Prestigious ERC grants awarded to Lund researchers 33
Nov 28, 2017: Molecular profiling of melanoma tumours explains differences in survival after T cell therapy 35
Nov 06, 2017: Helmsley Charitable Trust Awards $52 Million to Support the Global Platform for the Prevention of Autoimmune Diabetes 37
Nov 02, 2017: New research shows where in the brain the earliest signs of Alzheimers occur 39
Oct 25, 2017: New method helps rule out heart valve infection 41
Oct 05, 2017: Discovery of a new fusion gene class may affect the development of cancer 42
Sep 27, 2017: Grants to 18 research projects that may lead to future scientific breakthroughs 43
Jan 30, 2017: Unique mapping of methylome in insulin-producing islets 47
Product News 48
Jun 25, 2018: Fluorescent molecules reveal how cancer stem cells are selectively inhibited 48
May 29, 2017: New test method aims to predict allergenic potency of chemicals 49
Mar 12, 2018: New treatment for aggressive breast cancer 50
Mar 12, 2018: Aggressive breast cancer can be transformed into a treatable form 51
Other Significant Developments 52
Feb 06, 2017: An Innovative Medicines Initiative Project for Precision Medicine in DKD 52
Appendix 53
Methodology 53
About GlobalData 53
Contact Us 53
Disclaimer 53

List of Tables
Lund University, Pharmaceuticals & Healthcare, Key Facts 2
Lund University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Lund University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 7
Lund University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Lund University, Deals By Therapy Area, 2012 to YTD 2018 9
Lund University, Medical Devices Deals, 2012 to YTD 2018 10
Lund University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 11
RhoVac Enters into Research Agreement with Lund University 12
Rocket Pharma Entered into Research and Development Agreement with Lund University 13
Novo Nordisk Enters into Research and Licensing Agreement with Lund University 14
Avrobio Enters into Licensing Agreement with Lund University 15
Akuru Pharma Spin Out from Lund University 16
Lund University, Key Competitors 17
Lund University, Key Employees 18
Lund University, Other Locations 19
Lund University, Subsidiaries 19
Lund University, Joint Venture 20

List of Figures
Lund University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Lund University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Lund University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Lund University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Lund University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 6
Lund University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 7
Lund University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 8
Lund University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 9
Lund University, Medical Devices Deals, 2012 to YTD 2018 10

★海外企業調査レポート[Lund University:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Tessi S.A. (TES):企業の財務・戦略的SWOT分析
    Tessi S.A. (TES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the …
  • NOW Inc (DNOW):企業の財務・戦略的SWOT分析
    NOW Inc (DNOW) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the po …
  • Texas Health Resources:企業の戦略的SWOT分析
    Texas Health Resources - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and …
  • VA Tech Wabag Ltd (WABAG):企業の財務・戦略的SWOT分析
    Summary VA Tech Wabag Ltd (VA Tech) is engaged in the planning, design, installation and operation of water and wastewater plants. The company’s services include water treatment, desalination, waste water treatment, water reclamation, and sludge treatment. Its projects comprise Sundarijal Water Trea …
  • Emera Inc (EMA):電力:M&Aディール及び事業提携情報
    Summary Emera Inc (Emera) is an energy and services company. It invests in electricity, natural gas and utility energy services. Through ownership and equity investments in various companies, Emera generates, transmits and distributes electricity; procures, transmits and distributes natural gas; mar …
  • J.F. Shea Co Inc:企業の戦略・SWOT・財務分析
    J.F. Shea Co Inc - Strategy, SWOT and Corporate Finance Report Summary J.F. Shea Co Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • TherOx Inc:医療機器:M&Aディール及び事業提携情報
    Summary TherOx Inc (TherOx) is a medical device company that develops and commercializes SuperSaturated Oxygen (SSO2) therapies for treatment of heart attack. Its SSO2 therapy is designed to ameliorate progressive myocardial necrosis by minimizing microvascular damage in heart attack patients. TherO …
  • The Schwan Food Company:戦略・SWOT・企業財務分析
    The Schwan Food Company - Strategy, SWOT and Corporate Finance Report Summary The Schwan Food Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service off …
  • Perrigo Co Plc (PRGO):企業の財務・戦略的SWOT分析
    Perrigo Co Plc (PRGO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and …
  • Hewlett Packard Enterprise Company:企業の戦略・SWOT・財務情報
    Hewlett Packard Enterprise Company - Strategy, SWOT and Corporate Finance Report Summary Hewlett Packard Enterprise Company - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, p …
  • MS Amlin plc:企業の戦略的SWOT分析
    MS Amlin plc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. …
  • Camping World Holdings, Inc. (CWH):企業の財務・戦略的SWOT分析
    Camping World Holdings, Inc. (CWH) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and w …
  • Akers Biosciences Inc (AKER):企業の製品パイプライン分析2018
    Summary Akers Biosciences Inc (ABI) is a medical device company that develops, manufactures and supplies point-of-care screening and testing products. The company provides clinical diagnostics, safety diagnostics, and wellness products. Its products include BreathScan alcohol detectors, CHUBE, METRO …
  • Shopper’S Stop Ltd.:企業の戦略・SWOT・財務分析
    Shopper'S Stop Ltd. - Strategy, SWOT and Corporate Finance Report Summary Shopper'S Stop Ltd. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Granules India Ltd (GRANULES):企業の財務・戦略的SWOT分析
    Granules India Ltd (GRANULES) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • La-Z-Boy Inc (LZB):企業の財務・戦略的SWOT分析
    La-Z-Boy Inc (LZB) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and th …
  • Dentsply Sirona, Inc.:戦略・SWOT・企業財務分析
    Dentsply Sirona, Inc. - Strategy, SWOT and Corporate Finance Report Summary Dentsply Sirona, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Medivir AB:企業のM&A・事業提携・投資動向
    Medivir AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Medivir AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), divestments, capi …
  • Immune Pharmaceuticals Inc (IMNP):企業の財務・戦略的SWOT分析
    Summary Immune Pharmaceuticals Inc (Immune Pharma), formerly EpiCept Corp is a drug development company that develops novel therapies for immunologic and inflammatory diseases. The company’s pipeline products include Bertilimumab and Nanocyclo. Its Bertilimumab is a human monoclonal antibody designe …
  • GenePOC Inc-医療機器分野:企業M&A・提携分析
    Summary GenePOC Inc (GenePOC), a subsidiary of Debiopharm Group is a medical device company that develops rapid molecular devices for providing targeted therapy. The company offers on-the-spot diagnostic devices for achieving optimal patient management. It offers diagnostic instruments based on a no …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆